Remote radiography and fluoroscopy systems traditionally have appealed more to Europeans than to practitioners in the U.S. But Philips is betting the time-and design of its new Juno DRF-are right to make a change in old habits. The Juno DRF remote-controlled flat-detector system, recently cleared by the FDA, offers enhancements that Philips Healthcare is promoting in its RSNA booth as the means to faster workflow and patient throughput and maximized return on investment.
Remote radiography and fluoroscopy systems traditionally have appealed more to Europeans than to practitioners in the U.S. But Philips is betting the time-and design of its new Juno DRF-are right to make a change in old habits. The Juno DRF remote-controlled flat-detector system, recently cleared by the FDA, offers enhancements that Philips Healthcare is promoting in its RSNA booth as the means to faster workflow and patient throughput and maximized return on investment.
The system combines everything needed for digital radiography and fluoroscopy applications, including all common radiographic procedures, gastrointestinal studies, tomography, and vascular studies. Its open-access design, characterized by a 180-cm (71-inch) Source Image Distance (SID), or distance between the x-ray source and detector, and table capacity of up to 284 kg (626 pounds) position the system for use in bariatric studies, according to Philips.
For customers who prefer to work with controls nearby, Philips offers comprehensive digital radiofrequency room solutions with two digital detectors in a vertical stand or in the EasyDiagnost Eleva table, thereby combining high-quality digital radiography and fluoroscopy.
The ability to add a choice of components and the flexibility to upgrade the system anytime allow customers to create a room customizable to changing needs, according to the company, from a single-detector version to a high-end, full digital room solution.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.